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Human thromboxane (TX) synthase (EC 5.3.99.5) was produced by the baculovirus expression system using cDNA encoding human TX synthase 
[(1991) Biochem. Biophys. Res. Commun. 78, 1479-14841. A recombinant baculovirus TXS7 was expressed in Spodopterafrugiperda St9 insect cells. 
The expressed protein was recognized by monoclonal antibody, Kon 7 raised against human TX synthase [(1990) Blood 76, SCrSS]. The recombinant 
TX synthase catalyzed the conversion of prostaglandin (PC) Hz to TXA, and 12-hydroxy-heptadecatrienoic ac d (HHT). Both conversions of PGHz 
to TXAz and HHT by the expressed TX synthase were completely inhibited by a specific TX synthase inhibitor, OKY-046 (5 PM). 
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1. INTRODUCTION 
Thromboxane (TX) synthase catalyzes the conver- 
sion of prostaglandin (PG) H, to TXA, which has po- 
tent biological activities as a mediator of platelet aggre- 
gation or vasoconstriction [l-3]. TX synthase has been 
purified from human platelets [4,5] and porcine lung [6], 
and the properties of the enzymes have been character- 
ized. The molecular masses of human and porcine en- 
zymes were reported to be 60.5 [7] and 56 kDa [6], 
respectively. The enzyme contains 1 mol of heme per 
mol of the enzyme polypeptide. and a close analogy to 
the group of cytochrome P450 proteins was established 
by optical and EPR spectroscopy. 
Recently, we succeeded in cDNA cloning of human 
platelet TX synthase, and showed that the primary 
structure of the enzyme indicates a homology to those 
of the enzymes in cytochrome PJ5,, IIIA family, espe- 
cially to that of nifedipine oxidase [7]. The amino acid 
sequence constituting the heme-binding site of cyto- 
chrome P450 is well conserved in the deduced amino acid 
sequence of TX synthase [7]. On the other hand, Ohashi 
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et al. also have cloned the cDNA for the enzyme from 
human lung cDNA library [8]. 
The enzymatic and protein chemical characteriza- 
tions of TX synthase have been limited due to the diffi- 
culty in purification of the enzyme. In order to make 
more detailed studies on the structure and reaction 
mechanism of TX synthase, it is essential to establish an 
expression system for TX synthase. In this paper we 
report the expression of TX synthase cDNA using the 
baculovirus expression system and partial characteriza- 
tion of the expressed TX synthase. 
2. MATERIALS AND METHODS 
2.1. Materials 
Spodoptera frugiperda Sf9 cells and baculovirus transfer vector 
pVL1393 were obtained from Invitrogen. Grace’s insect cell culture 
medium was the product of Gibco. [ I-“C]Arachidonic acid (1.85 GBqI 
mmol) was purchased from Amersham. OKY-046, authentic PGE,, 
PGFZ. and TXBz were given from ON0 Pharmaceutical Co. (Osaka). 
All other reagents for construction of the recombinant baculovirus 
were described previously [7,9]. 
2.2. Construction of baculovwus transfer vector of TX synthase 
(TXS726) 
The human TX synthase cDNA [7] was inserted into the BarnHI and 
XbaI sites of pVL1393 transfer vector. pHPTXS6 was digested with 
SphI and ligated with XbaI linker after treatment with Klenow DNA 
polymerase I. The EcoRI (site 653tXbaI fragment (1,064 bp) of the 
cDNA prepared from pHPTXS6 and the SacI-EcoRI fragment (sites 
21&652) from pHPTXS2 were ligated and inserted mto Sac1 and XbaI 
sites of pBluescript II SK(-)(pHPTXS26). The BarnHI-Sac1 (site 209) 
fragment (227 bp) containing 8 bp of multicloning site of the 
pBIuescript II was prepared from pHPTXS7, which was obtained by 
cloning into pBluescript II the polymerase chain reaction product with 
the primers 4 and 15 as described previously [7]. This BarnHI-Sac1 
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Fig. I. Western immunoblot analysis of the expressed TX synthase in Sf9 cells. Microsomai fractions were prepared from baculovi~s-inf~ted St9 
ceils treated with (lanes 1-3) or without (lanes 4-6) 10pM hemin as described m section 2. Microsomes from human platelets were also isolated 
by the same procedure. The microsomal fractions (25 ,ug of protein) were subjected to western immunoblot analysis using monoclonai antibody 
(Kon 7) against human platelet TX synthase. Lanes I and 4, mock-infected cells: lanes 2 and 5, wild-type AcNPV-mfected cells; lanes 3 and 6. 
TXS7-infected cells; lane 7. human platelets. 
fragment and the ScrcI-XbaI fragment (1,507 bp) from pHPTXS26 
were ligated and inserted into the BarnHI and X&I sites of the 
pVL1393 transfer vector (TXS726). The construct of each recombi- 
nant plasmid was confirmed by the restriction mapping or DNA 
sequencing analysis. 
Sf9 cells were maintamed in monolayer culture in Grace’s insect 
medium supplemented with 10% fetal bovme serum, 0.33% yeastolate 
and 0.33% lactalbumin hydrolysate at 27°C [lo]. To produce a recom- 
binant virus, Sf9 cells (1.5 x lOh cells) was transfected with a mixture 
of the recombinant piasmid TXS726 (5Opg) and wild-type baculovirus 
DNA (AcNPV; 1 @gf by the calcium-phosphate precipitatton method. 
A recombinant baculovirus TXS7 was isolated by the combmation of 
plaque assay and slot blot hybridization using “‘P-labeled cDNA frag- 
ments of TX synthase as probes, and amplified for further use. St9 
cells were infected with a wild-type (AcNPV) or the r~omb~nant 
(TXS7) baculovirus. At 3 days after infection, the cells were harvested 
(2 x lo* cells) and incubated for 5 h with or without 10 fiuM hemin m 
the serum-supplemented medium. The cells were washed with phos- 
phate-buffered saline and stored at -80°C. The microsomal fracttons 
of the cells were prepared aceordmg to the method of Haurand and 
Ullnch 141. The cells (2 x IO* cells) were homogenized in 20 ml of IO 
mM potassium phosphate buffer (pH 7.0). IO mM EDTA. 5 mM 
glucose. 0. I mM dithiothreitol (DTT), 1.15% KCI. 2 pg/ml leupeptm, 
2 pg/mi pepstatin, 10 ,@ml soybean trypsin inhibitor, and 44 &ml 
phenylmethylsulfonyl fluoride, and somcated 4 times with a Branson 
sonifier model 450 for 30 s. The homogenate was centrifuged at 
7.000 xg for 1.5 min and the supernatant was centrifuged at 
105.000 x g for 60 min. Pellets were suspended m 3 ml of 10 mM 
potassium phosphate buffer (pH 7.0) containing 20% glycerol, 1mM 
DTT and I mM EDTA by sonication. Protein concentration was 
determmed by the method of Lowry [I l] using bovine serum albumin 
92 
as a standard, and adjusted to 5 mg/ml with the same solution for 
immunoblot analysis and TX synthase assay. 
Microsomal fractions from infected Sf9 cells and human platelet 
were subjected to 10% SDS-PAGE by the method of Laemmh [12]. 
The proteins were transferred electrophoreti~aIiy onto a polyvi- 
nylidene dtfluoride (PVDF) membrane (Immobilon, Milllpore) ac- 
cording to the method of Towbin et al. [13]. After pretreatment with 
10% horse serum in Trts-HCI-buffered saline (TBS). pH 7.4, at room 
temperature for 30 min. the blotted membrane was incubated with the 
monoclonal antibody against human pIatelet TXA synthase. Kon 7 
[14,15] in TBS containing 3% skim milk. After rinsing with TBS 
containing 0.05% Tween 20. the membrane was incubated wtth anti- 
mouse IgG horse antibody conjugated with horseradish peroxidase 
(Vector Laboratories) in TBS containing 3% skim milk at 37°C for 
30 min. After successive washings with TBS containing 0.05% Tween 
20 and then with TBS, immunoreactive bands were detected by the 
Immunostaming HRP kit (Konica, Tokyo). 
[I-“‘CJPGHZ was prepared from [l-‘4C]arachldonlc acid usmg ml- 
crosomes of sheep vesicular glands, and TX synthase assay was carrted 
out as described m [16]. Briefly, the standard reaction mixture for TX 
synthase assay contained 0.1 M Tris-HCI buffer at pH 7.4, [l- 
“C]PGHI (80,000 cpm/S nmol dissolved m 5 pi of acetone) and an 
enzyme preparation in a final volume of 100 ~1. The reaction was 
carried out at 24°C for 1 min and terminated by the addition of 0.3 
ml of a mrxture of ethyl ether/methanol/O.2 M citric acid (30:4:1). The 
organic phase (loo@) was directly applied on a silica gel plate at 4°C. 
and the plate was developed at room temperature using an organic 
layer of ethyl ace~te/2,2.4-trlmethyipentane/a~tic acid/water 
(110:50:20:100). The radioactivity of the plates was monttored using 
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Fig. 2. Formation of TXB2 and HHT from PGHz by microsomes from infected St9 cells. Microsomal fractions were prepared from the baculovirus- 
infected St9 cells treated with (lanes 2-5) or without (lane 6) 10 PM hemin as described in Fig. 1. Microsomal fractions (5 pg of protein) were 
incubated with 50 PM [l-‘%Z]PGH, at 24°C for 1 min in the presence (lane 5) or absence (lanes 24 and 6) of 5 PM OKY-046 as described in section 
2. The reaction products were separated by thin-layer chromatography and radioactive products were detected by a Fujix Bio-image analyzer BAS 
2000. Authentic TXB2, PGE, and PGF?, were also run. Migrations of PGH2, TXB?. HHT, PGE, and PGFza are indicated by the arrowheads. Lane 
1, no enzyme preparation; lane 2, mock-infected cells; lane 3, wild-type virus (AcNPV)-infected cells; lanes 4-6, TXS7-infected cells. 
either an Imaging Scanner System 400 (Packard) or a Fujtx BAS 2000 
Bio-Imaging analyzer (Fuji Photo Film Co., Tokyo). 
3. RESULTS AND DISCUSSION 
It has been shown by optical and EPR spectroscopic 
studies on human platelet TX synthase that the enzyme 
is a cytochrome P,,,-like protein [4,5]. This finding has 
been confirmed by cDNA cloning of the enzyme. 
Namely, the primary structure of the enzyme deduced 
from the nucleotide sequence of the cDNA for the en- 
zyme has a homology with those of cytochrome P,,,s. 
Especially, the sequence around the cysteine (residue 
479) which probably constitutes the fifth ligand of heme 
exhibits a highly conserved sequence [7,8]. 
The study on TX synthase, however, has been re- 
stricted due to the difficulty in obtaining sufficient 
amount of the enzyme. Thus, we tried to express TX 
synthase with our cloned human TX synthase cDNA 
using the baculovirus expression system. Recently, 
many investigators succeeded in expression of mem- 
brane proteins by the baculovirus expression system. 
Several cytochrome P450s were also expressed by this 
system. Asseffa et al. reported that exogenous hemin 
added in the culture medium increased the enzyme ac- 
tivity of cytochrome P,,, IIAl by conversion of the 
expressed apoenzyme to the holoenzyme, and the bacu- 
lovirus expression system can be used as a system to 
produce high levels of mammalian cytochrome Pd5,,s 
containing custom modified heme moieties [17]. 
For expression of the recombinant TX synthase, a 
recombinant baculovirus (TXS7) with an insert of the 
entire protein-coding region of human TX synthase 
gene was constructed and expressed in Sf9 cells. Previ- 
ously, Ntising et al. prepared several polyclonal and 
monoclonal antibodies against human platelet TX syn- 
thase and characterized [ 14,151. Western immunoblot 
analysis of the expressed protein in St9 cells was carried 
out using the monoclonal antibody Kon 7. TX synthase 
was purified from microsomal fractions [4,5], and Ohta 
et al. showed by immunoelectronmicroscopy that the 
expressed cytochrome Pd5,, Fl was linked to the endo- 
plasmic reticulum of the recombinant virus-infected Sl9 
cells [18]. Thus, microsomal fractions of the infected 
cells were subjected to immunoblot analysis. As shown 
in Fig. 1, an immunoreactive band appeared in the mi- 
crosomal fraction from TXS7-infected cells (lanes 3 and 
6). The positive band migrated at a molecular mass of 
approximately 58 kDa and was indistinguishable from 
human platelet TX synthase (lane 7). No immunoreac- 
tive band was found in the mock or wild-type AcNPV- 
infected cells (lanes 1. 2, 4 and 5). These results suggest 
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that the human TX synthase protein was expressed in 
TXS7-infected cells. The ratio of immunochemical sig- 
nals of TX synthase from TXS7-infected cells and 
human platelets was about 2:l. The intensity of the 
immunoreactive band from the cells incubated in the 
absence of exogenous hemin for 5 h before collection of 
cells was practically the same with that of the cells incu- 
bated in the presence of hemin (lanes 3 and 6). Thus, the 
treatment with hemin did not influence the synthesis of 
TX synthase apoprotein as found in the expression of 
other cytochrome P,sOs [17,181. 
To examine the TX synthase activity of the recombi- 
nant protein, the microsomal fractions from the infected 
cells were incubated with 14C-labeled PGH, as a sub- 
strate and the radioactive products were separated by 
silica gel thin layer chromatography (Fig. 2). When the 
microsomal fraction from TXS7-infected cells incu- 
bated in the culture medium containing 10 ,uM hemin 
for 5 h was incubated with PGH,, PGH, was converted 
to HHT and TXBz which is a stable degradation prod- 
uct of TXA, (Fig. 2, lane 4). The TXB,-forming activity 
of the microsome was 130 nmol/min/mg protein, which 
is about twice as much as that of human platelet micro- 
some [4]. Furthermore, the production of TXBz and 
HHT was completely inhibited by 5 ,DM OKY-046 that 
is a specific inhibitor for TX synthase [19] as shown in 
Fig. 3 (lane 5). These results suggest that Sf9 cells in- 
fected with TXS7 have expressed an active TX synthase. 
But, the purified human enzyme produced TXB? and 
HHT from PGH, with a ratio of 1: 1 [4,5]. The ratio of 
TXB, and HHT formed by the microsomal fraction 
from TXS7-infected cells was approximately 1: 1.8. The 
discrepancy may be ascribed to crude enzyme prepara- 
tions used for the enzymatic reactions such as micro- 
somes [16]. The treatment of the TXS7-infected cells 
with hemin for 5 h did not affect the increase in the TX 
synthase activity. This result suggests that most of the 
expressed TX synthase protein existed as the holoen- 
zyme probably due to the sufficient supply of heme in 
the Sf9 cells at the level of expression of TX synthase 
in this study. 
We are now attempting to express a larger amount of 
TX synthase for detailed studies on the structure and 
LETTERS February 199.1 
reaction mechanism of TX synthase. The site-directed 
mutagenesis tudy is also now in progress. 
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